CoChat
Sign Up
Cited by 40

Is It worth Considering Circulating microRNAs in Multiple Sclerosis?

Jagot, Ferdinand, Davoust, Nathalie·2016·Frontiers in Immunology
DOI 10.3389/fimmu.2016.00129PMC PMC4821089
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2016.00129

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 63

  1. [1]Filipowicz W Bhattacharyya SN Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet (2008) 9: 102– 14. 10.1038/nrg2290 18197166 · DOI
  2. [2]Winter J Jung S Keller S Gregory RI Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol (2009) 11: 228– 34. 10.1038/ncb0309-228 19255566 · DOI
  3. [3]Du C Liu C Kang J Zhao G Ye Z Huang S microRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol (2009) 10: 1252– 9. 10.1038/ni.1798 19838199 · DOI · Paper page
  4. [4]Junker A Krumbholz M Eisele S Mohan H Augstein F Bittner R microRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain (2009) 132: 3342– 52. 10.1093/brain/awp300 19952055 · DOI · Paper page
  5. [5]Zhang J Cheng Y Cui W Li M Li B Guo L. microRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol (2014) 266: 56– 63. 10.1016/j.jneuroim.2013.09.019 24332164 · DOI
  6. [6]Murugaiyan G da Cunha AP Ajay AK Joller N Garo LP Kumaradevan S microRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Invest (2015) 125: 1069– 80. 10.1172/JCI74347 25642768 PMC4362225 · DOI
  7. [7]Zhu E Wang X Zheng B Wang Q Hao J Chen S miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3. J Immunol (2014) 192: 5599– 609. 10.4049/jimmunol.1303488 24842756 · DOI
  8. [8]Hoy AM Buck AH. Extracellular small RNAs: what, where, why? Biochem Soc Trans (2012) 40: 886– 90. 10.1042/BST20120019 22817753 PMC3433256 · DOI
  9. [9]Gandhi R Healy B Gholipour T Egorova S Musallam A Hussain MS Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol (2013) 73: 729– 40. 10.1002/ana.23880 23494648 · DOI
  10. [10]Søndergaard HB Hesse D Krakauer M Sørensen PS Sellebjerg F. Differential microRNA expression in blood in multiple sclerosis. Mult Scler (2013) 19: 1849– 57. 10.1177/1352458513490542 23773985 · DOI
  11. [11]Siegel SR Mackenzie J Chaplin G Jablonski NG Griffiths L. Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep (2012) 39: 6219– 25. 10.1007/s11033-011-1441-7 22231906 · DOI
  12. [12]Farina NH Wood ME Perrapato SD Francklyn CS Stein GS Stein JL Standardizing analysis of circulating microRNA: clinical and biological relevance. J Cell Biochem (2014) 115: 805– 11. 10.1002/jcb.24745 24357537 PMC3992702 · DOI
  13. [13]Keller A Leidinger P Steinmeyer F Stähler C Franke A Hemmrich-Stanisak G Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler (2014) 20: 295– 303. 10.1177/1352458513496343 23836875 · DOI
  14. [14]Bergman P James T Kular L Ruhrmann S Kramarova T Kvist A Next-generation sequencing identifies microRNAs that associate with pathogenic autoimmune neuroinflammation in rats. J Immunol (2013) 190: 4066– 75. 10.4049/jimmunol.1200728 23514736 PMC3619525 · DOI
  15. [15]Zhao S Fung-Leung W-P Bittner A Ngo K Liu X. Comparison of RNA-seq and microarray in transcriptome profiling of activated T cells. PLoS One (2014) 9: e78644. 10.1371/journal.pone.0078644 24454679 PMC3894192 · DOI
  16. [16]Xu X Zhang Y Williams J Antoniou E McCombie WR Wu S Parallel comparison of Illumina RNA-seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets. BMC Bioinformatics (2013) 14(Suppl 9): S1. 10.1186/1471-2105-14-S9-S1 23902433 PMC3697991 · DOI
  17. [17]Knowles DG Röder M Merkel A Guigó R. Grape RNA-seq analysis pipeline environment. Bioinformatics (2013) 29: 614– 21. 10.1093/bioinformatics/btt016 23329413 PMC3582270 · DOI
  18. [18]Fenoglio C Ridolfi E Cantoni C De Riz M Bonsi R Serpente M Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Mult Scler (2013) 19: 1938– 42. 10.1177/1352458513485654 24277735 · DOI
  19. [19]Cox MB Cairns MJ Gandhi KS Carroll AP Moscovis S Stewart GJ microRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One (2010) 5: e12132. 10.1371/journal.pone.0012132 20711463 PMC2920328 · DOI
  20. [20]Sievers C Meira M Hoffmann F Fontoura P Kappos L Lindberg RLP. Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clin Immunol (2012) 144: 70– 9. 10.1016/j.clim.2012.04.002 22659298 · DOI
  21. [21]Miyazaki Y Li R Rezk A Misirliyan H Moore C Farooqi N A novel microRNA-132-surtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis. PLoS One (2014) 9: e105421 10.1371/journal.pone.0105421 25136908 PMC4138149 · DOI
  22. [22]Lindberg RLP Hoffmann F Mehling M Kuhle J Kappos L. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur J Immunol (2010) 40: 888– 98. 10.1002/eji.200940032 20148420 · DOI
  23. [23]Lorenzi JCC Brum DG Zanette DL de Paula Alves Souza A Barbuzano FG Dos Santos AC miR-15a and 16-1 are downregulated in CD4+ T cells of multiple sclerosis relapsing patients. Int J Neurosci (2012) 122: 466– 71. 10.3109/00207454.2012.678444 22463747 · DOI
  24. [24]De Santis G Ferracin M Biondani A Caniatti L Rosaria Tola M Castellazzi M Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol (2010) 226: 165– 71. 10.1016/j.jneuroim.2010.06.009 20637509 · DOI
  25. [25]Jernås M Malmeström C Axelsson M Nookaew I Wadenvik H Lycke J microRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol (2013) 14: 32. 10.1186/1471-2172-14-32 23895517 PMC3734042 · DOI
  26. [26]Guerau-de-Arellano M Smith KM Godlewski J Liu Y Winger R Lawler SE micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain (2011) 134: 3578– 89. 10.1093/brain/awr262 22088562 PMC3235556 · DOI
  27. [29]Noorbakhsh F Ellestad KK Maingat F Warren KG Han MH Steinman L Impaired neurosteroid synthesis in multiple sclerosis. Brain (2011) 134: 2703– 21. 10.1093/brain/awr200 21908875 PMC4141444 · DOI
  28. [30]Dutta R Chomyk AM Chang A Ribaudo MV Deckard SA Doud MK Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors. Ann Neurol (2013) 73: 637– 45. 10.1002/ana.23860 23595422 PMC3679350 · DOI
  29. [31]Lu C Huang X Zhang X Roensch K Cao Q Nakayama KI miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood (2011) 117: 4293– 303. 10.1182/blood-2010-12-322503 21355095 PMC3087479 · DOI
  30. [32]Grigoryev YA Kurian SM Hart T Nakorchevsky AA Chen C Campbell D microRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. J Immunol (2011) 187: 2233– 43. 10.4049/jimmunol.1101233 21788445 PMC3159804 · DOI
  31. [33]György B Szabó TG Pásztói M Pál Z Misják P Aradi B Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci (2011) 68: 2667– 88. 10.1007/s00018-011-0689-3 21560073 PMC3142546 · DOI
  32. [34]Pegtel DM Cosmopoulos K Thorley-Lawson DA van Eijndhoven MAJ Hopmans ES Lindenberg JL Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A (2010) 107: 6328– 33. 10.1073/pnas.0914843107 20304794 PMC2851954 · DOI
  33. [35]Gibbings DJ Ciaudo C Erhardt M Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol (2009) 11: 1143– 9. 10.1038/ncb1929 19684575 · DOI
  34. [36]Hunter MP Ismail N Zhang X Aguda BD Lee EJ Yu L Detection of microRNA expression in human peripheral blood microvesicles. PLoS One (2008) 3: e3694. 10.1371/journal.pone.0003694 19002258 PMC2577891 · DOI
  35. [37]Zernecke A Bidzhekov K Noels H Shagdarsuren E Gan L Denecke B Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal (2009) 2: ra81– 81. 10.1126/scisignal.2000610 19996457 · DOI
  36. [38]Arroyo JD Chevillet JR Kroh EM Ruf IK Pritchard CC Gibson DF Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 108: 5003– 8. 10.1073/pnas.1019055108 21383194 PMC3064324 · DOI · Paper page
  37. [39]Wang K Zhang S Weber J Baxter D Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res (2010) 38: 7248– 59. 10.1093/nar/gkq601 20615901 PMC2978372 · DOI · Paper page
  38. [40]Vickers KC Palmisano BT Shoucri BM Shamburek RD Remaley AT. microRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol (2011) 13: 423– 33. 10.1038/ncb2210 21423178 PMC3074610 · DOI · Paper page
  39. [41]Sáenz-Cuesta M Irizar H Castillo-Triviño T Muñoz-Culla M Osorio-Querejeta I Prada A Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis. Biomark Med (2014) 8: 653– 61. 10.2217/bmm.14.9 25123034 · DOI
  40. [42]Sáenz-Cuesta M Osorio-Querejeta I Otaegui D. Extracellular vesicles in multiple sclerosis: what are they telling us? Front Cell Neurosci (2014) 8: 100. 10.3389/fncel.2014.00100 24734004 PMC3975116 · DOI
  41. [43]Ridder K Keller S Dams M Rupp A-K Schlaudraff J Turco DD Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol (2014) 12: e1001874. 10.1371/journal.pbio.1001874 24893313 PMC4043485 · DOI · Paper page
  42. [44]Okoye IS Coomes SM Pelly VS Czieso S Papayannopoulos V Tolmachova T microRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity (2014) 41: 89– 103. 10.1016/j.immuni.2014.05.019 25035954 PMC4104030 · DOI
  43. [45]Walker JD Maier CL Pober JS. Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes. J Immunol (2009) 182: 1548– 59. 10.4049/jimmunol.182.3.1548 19155503 PMC2630120 · DOI
  44. [46]Jy W Minagar A Jimenez JJ Sheremata WA Mauro LM Horstman LL Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci (2004) 9: 3137– 44. 10.2741/1466 15353343 · DOI
  45. [47]Hwang I Shen X Sprent J. Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc Natl Acad Sci U S A (2003) 100: 6670– 5. 10.1073/pnas.1131852100 12743365 PMC164505 · DOI
  46. [48]Allan RS Waithman J Bedoui S Jones CM Villadangos JA Zhan Y Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity (2006) 25: 153– 62. 10.1016/j.immuni.2006.04.017 16860764 · DOI
  47. [49]Pizzirani C Ferrari D Chiozzi P Adinolfi E Sandonà D Savaglio E Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood (2007) 109: 3856– 64. 10.1182/blood-2005-06-031377 17192399 · DOI
  48. [50]Blanchard N Lankar D Faure F Regnault A Dumont C Raposo G Activation of human T cells induces the production of exosomes bearing the TCR/CD3/ζ complex. J Immunol (2002) 168: 3235– 41. 10.4049/jimmunol.168.7.3235 11907077 · DOI · Paper page
  49. [51]MacKenzie A Wilson HL Kiss-Toth E Dower SK North RA Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity (2001) 15: 825– 35. 10.1016/S1074-7613(01)00229-1 11728343 · DOI
  50. [52]Antonucci F Turola E Riganti L Caleo M Gabrielli M Perrotta C Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO J (2012) 31: 1231– 40. 10.1038/emboj.2011.489 22246184 PMC3297996 · DOI · Paper page
  51. [53]Bakhti M Winter C Simons M. Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosome-like vesicles. J Biol Chem (2011) 286: 787– 96. 10.1074/jbc.M110.190009 20978131 PMC3013037 · DOI
  52. [54]Basso M Pozzi S Tortarolo M Fiordaliso F Bisighini C Pasetto L Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem (2013) 288: 15699– 711. 10.1074/jbc.M112.425066 23592792 PMC3668729 · DOI
  53. [55]Meinl E Krumbholz M Derfuss T Junker A Hohlfeld R. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis. J Neurol Sci (2008) 274: 42– 4. 10.1016/j.jns.2008.06.032 18715571 · DOI
  54. [56]Lovett-Racke AE Yang Y Racke MK. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta (2011) 1812: 246– 51. 10.1016/j.bbadis.2010.05.012 20600875 PMC3004998 · DOI
  55. [57]O’Connell RM Kahn D Gibson WSJ Round JL Scholz RL Chaudhuri AA microRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity (2010) 33: 607– 19. 10.1016/j.immuni.2010.09.009 20888269 PMC2966521 · DOI · Paper page
  56. [58]Brucklacher-Waldert V Stuerner K Kolster M Wolthausen J Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain (2009) 132: 3329– 41. 10.1093/brain/awp289 19933767 · DOI
  57. [59]Polman CH Reingold SC Banwell B Clanet M Cohen JA Filippi M Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 69: 292– 302. 10.1002/ana.22366 21387374 PMC3084507 · DOI · Paper page
  58. [60]Haghikia A Haghikia A Hellwig K Baraniskin A Holzmann A Décard BF Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology (2012) 79: 2166– 70. 10.1212/WNL.0b013e3182759621 23077021 · DOI
  59. [61]Swanton JK Rovira A Tintore M Altmann DR Barkhof F Filippi M MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol (2007) 6: 677– 86. 10.1016/S1474-4422(07)70176-X 17616439 · DOI
  60. [62]Bitsch A Brück W. Differentiation of multiple sclerosis subtypes: implications for treatment. CNS Drugs (2002) 16: 405– 18. 10.2165/00023210-200216060-00004 12027786 · DOI
  61. [63]Waschbisch A Atiya M Linker RA Potapov S Schwab S Derfuss T. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS One (2011) 6: e24604. 10.1371/journal.pone.0024604 21949733 PMC3174971 · DOI
  62. [64]Meira M Sievers C Hoffmann F Derfuss T Kuhle J Kappos L miR-126: a novel route for natalizumab action? Mult Scler (2014) 20: 1363– 70. 10.1177/1352458514524998 24598267 · DOI
  63. [65]Meira M Sievers C Hoffmann F Rasenack M Kuhle J Derfuss T Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis. J Immunol Res (2014) 2014: 897249. 10.1155/2014/897249 24901013 PMC4036714 · DOI

Cited by

Sorted by citations

Authors
Jagot, F., & Davoust, N.
Venue
Frontiers in Immunology
Publisher
Frontiers Media SA
Published
2016-04-05
Volume
7
ISSN
1664-3224
DOI
10.3389/fimmu.2016.00129
PMC
PMC4821089
Cited by
40
References
2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review